APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hydrocortisone Injection

Compare research editions
View pricing & licenses

Selected research

Industry Research

Hydrocortisone Injection Industry Research Report 2026

20 December 2025139 pages

Choose your research edition.

Industry ResearchHydrocortisone Injection Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Hydrocortisone Injection Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Hydrocortisone Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hydrocortisone Injection Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Hydrocortisone Injection Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Hydrocortisone Injection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Hydrocortisone Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Hydrocortisone Injection is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Hydrocortisone Injection is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Hydrocortisone Injection include Southwest Pharmaceutical, KINGYOR, Shiyao YINHU Pharmaceutical, CSPC Ouyi Pharmaceutical, Maanshan Fengyuan Pharmaceutical, Jiangsu Lianhuan Pharmaceutical, Jiangsu Kangbao Pharmaceutical, Pfizer and HUAZHONG Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Hydrocortisone Injection market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Hydrocortisone Injection Market by Company

Southwest Pharmaceutical

KINGYOR

Shiyao YINHU Pharmaceutical

CSPC Ouyi Pharmaceutical

Maanshan Fengyuan Pharmaceutical

Jiangsu Lianhuan Pharmaceutical

Jiangsu Kangbao Pharmaceutical

Pfizer

HUAZHONG Pharmaceutical

Hubei Zhongjiachem Pharmaceutical

Hebei Tiancheng Pharmaceutical

Dalian Holley Kingkong Pharmaceutical

Chengdu No.1 Pharmaceutical

BIOZEN Pharmaceutical

Anhui Changjiang Pharmaceutical

Anhui Chengshi Pharmaceutical

Hydrocortisone Injection Segment by Type

Intramuscular Injection

Intravenous Drip

Hydrocortisone Injection Segment by Application

Hospital

Clinics

Other

Hydrocortisone Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hydrocortisone Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hydrocortisone Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hydrocortisone Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Hydrocortisone Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Hydrocortisone Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Hydrocortisone Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Hydrocortisone Injection Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Hydrocortisone Injection Sales (k units) of Manufacturers (2021-2026) Table 7. Global Hydrocortisone Injection Sales Market Share by Manufacturers (2021-2026) Table 8. Global Hydrocortisone Injection Revenue of Manufacturers (2021-2026) Table 9. Global Hydrocortisone Injection Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Hydrocortisone Injection Average Price (US$/unit) of Manufacturers (2021-2026) Table 11. Global Hydrocortisone Injection Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Hydrocortisone Injection, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Hydrocortisone Injection, Product Type & Application Table 14. Global Hydrocortisone Injection Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Hydrocortisone Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Southwest Pharmaceutical Company Information Table 19. Southwest Pharmaceutical Business Overview Table 20. Southwest Pharmaceutical Hydrocortisone Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 21. Southwest Pharmaceutical Hydrocortisone Injection Product Portfolio Table 22. Southwest Pharmaceutical Recent Developments Table 23. KINGYOR Company Information Table 24. KINGYOR Business Overview Table 25. KINGYOR Hydrocortisone Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 26. KINGYOR Hydrocortisone Injection Product Portfolio Table 27. KINGYOR Recent Developments Table 28. Shiyao YINHU Pharmaceutical Company Information Table 29. Shiyao YINHU Pharmaceutical Business Overview Table 30. Shiyao YINHU Pharmaceutical Hydrocortisone Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 31. Shiyao YINHU Pharmaceutical Hydrocortisone Injection Product Portfolio Table 32. Shiyao YINHU Pharmaceutical Recent Developments Table 33. CSPC Ouyi Pharmaceutical Company Information Table 34. CSPC Ouyi Pharmaceutical Business Overview Table 35. CSPC Ouyi Pharmaceutical Hydrocortisone Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 36. CSPC Ouyi Pharmaceutical Hydrocortisone Injection Product Portfolio Table 37. CSPC Ouyi Pharmaceutical Recent Developments Table 38. Maanshan Fengyuan Pharmaceutical Company Information Table 39. Maanshan Fengyuan Pharmaceutical Business Overview Table 40. Maanshan Fengyuan Pharmaceutical Hydrocortisone Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 41. Maanshan Fengyuan Pharmaceutical Hydrocortisone Injection Product Portfolio Table 42. Maanshan Fengyuan Pharmaceutical Recent Developments Table 43. Jiangsu Lianhuan Pharmaceutical Company Information Table 44. Jiangsu Lianhuan Pharmaceutical Business Overview Table 45. Jiangsu Lianhuan Pharmaceutical Hydrocortisone Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Jiangsu Lianhuan Pharmaceutical Hydrocortisone Injection Product Portfolio Table 47. Jiangsu Lianhuan Pharmaceutical Recent Developments Table 48. Jiangsu Kangbao Pharmaceutical Company Information Table 49. Jiangsu Kangbao Pharmaceutical Business Overview Table 50. Jiangsu Kangbao Pharmaceutical Hydrocortisone Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 51. Jiangsu Kangbao Pharmaceutical Hydrocortisone Injection Product Portfolio Table 52. Jiangsu Kangbao Pharmaceutical Recent Developments Table 53. Pfizer Company Information Table 54. Pfizer Business Overview Table 55. Pfizer Hydrocortisone Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 56. Pfizer Hydrocortisone Injection Product Portfolio Table 57. Pfizer Recent Developments Table 58. HUAZHONG Pharmaceutical Company Information Table 59. HUAZHONG Pharmaceutical Business Overview Table 60. HUAZHONG Pharmaceutical Hydrocortisone Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. HUAZHONG Pharmaceutical Hydrocortisone Injection Product Portfolio Table 62. HUAZHONG Pharmaceutical Recent Developments Table 63. Hubei Zhongjiachem Pharmaceutical Company Information Table 64. Hubei Zhongjiachem Pharmaceutical Business Overview Table 65. Hubei Zhongjiachem Pharmaceutical Hydrocortisone Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Hubei Zhongjiachem Pharmaceutical Hydrocortisone Injection Product Portfolio Table 67. Hubei Zhongjiachem Pharmaceutical Recent Developments Table 68. Hebei Tiancheng Pharmaceutical Company Information Table 69. Hebei Tiancheng Pharmaceutical Business Overview Table 70. Hebei Tiancheng Pharmaceutical Hydrocortisone Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Hebei Tiancheng Pharmaceutical Hydrocortisone Injection Product Portfolio Table 72. Hebei Tiancheng Pharmaceutical Recent Developments Table 73. Dalian Holley Kingkong Pharmaceutical Company Information Table 74. Dalian Holley Kingkong Pharmaceutical Business Overview Table 75. Dalian Holley Kingkong Pharmaceutical Hydrocortisone Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Dalian Holley Kingkong Pharmaceutical Hydrocortisone Injection Product Portfolio Table 77. Dalian Holley Kingkong Pharmaceutical Recent Developments Table 78. Chengdu No.1 Pharmaceutical Company Information Table 79. Chengdu No.1 Pharmaceutical Business Overview Table 80. Chengdu No.1 Pharmaceutical Hydrocortisone Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Chengdu No.1 Pharmaceutical Hydrocortisone Injection Product Portfolio Table 82. Chengdu No.1 Pharmaceutical Recent Developments Table 83. BIOZEN Pharmaceutical Company Information Table 84. BIOZEN Pharmaceutical Business Overview Table 85. BIOZEN Pharmaceutical Hydrocortisone Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. BIOZEN Pharmaceutical Hydrocortisone Injection Product Portfolio Table 87. BIOZEN Pharmaceutical Recent Developments Table 88. Anhui Changjiang Pharmaceutical Company Information Table 89. Anhui Changjiang Pharmaceutical Business Overview Table 90. Anhui Changjiang Pharmaceutical Hydrocortisone Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Anhui Changjiang Pharmaceutical Hydrocortisone Injection Product Portfolio Table 92. Anhui Changjiang Pharmaceutical Recent Developments Table 93. Anhui Chengshi Pharmaceutical Company Information Table 94. Anhui Chengshi Pharmaceutical Business Overview Table 95. Anhui Chengshi Pharmaceutical Hydrocortisone Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Anhui Chengshi Pharmaceutical Hydrocortisone Injection Product Portfolio Table 97. Anhui Chengshi Pharmaceutical Recent Developments Table 98. Global Hydrocortisone Injection Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 99. Global Hydrocortisone Injection Sales by Region (2021-2026) & (k units) Table 100. Global Hydrocortisone Injection Sales Market Share by Region (2021-2026) Table 101. Global Hydrocortisone Injection Sales by Region (2027-2032) & (k units) Table 102. Global Hydrocortisone Injection Sales Market Share by Region (2027-2032) Table 103. Global Hydrocortisone Injection Revenue by Region (2021-2026) & (US$ Million) Table 104. Global Hydrocortisone Injection Revenue Market Share by Region (2021-2026) Table 105. Global Hydrocortisone Injection Revenue by Region (2027-2032) & (US$ Million) Table 106. Global Hydrocortisone Injection Revenue Market Share by Region (2027-2032) Table 107. North America Hydrocortisone Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. North America Hydrocortisone Injection Sales by Country (2021-2026) & (k units) Table 109. North America Hydrocortisone Injection Sales by Country (2027-2032) & (k units) Table 110. North America Hydrocortisone Injection Revenue by Country (2021-2026) & (US$ Million) Table 111. North America Hydrocortisone Injection Revenue by Country (2027-2032) & (US$ Million) Table 112. Europe Hydrocortisone Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. Europe Hydrocortisone Injection Sales by Country (2021-2026) & (k units) Table 114. Europe Hydrocortisone Injection Sales by Country (2027-2032) & (k units) Table 115. Europe Hydrocortisone Injection Revenue by Country (2021-2026) & (US$ Million) Table 116. Europe Hydrocortisone Injection Revenue by Country (2027-2032) & (US$ Million) Table 117. Asia Pacific Hydrocortisone Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. Asia Pacific Hydrocortisone Injection Sales by Country (2021-2026) & (k units) Table 119. Asia Pacific Hydrocortisone Injection Sales by Country (2027-2032) & (k units) Table 120. Asia Pacific Hydrocortisone Injection Revenue by Country (2021-2026) & (US$ Million) Table 121. Asia Pacific Hydrocortisone Injection Revenue by Country (2027-2032) & (US$ Million) Table 122. South America Hydrocortisone Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. South America Hydrocortisone Injection Sales by Country (2021-2026) & (k units) Table 124. South America Hydrocortisone Injection Sales by Country (2027-2032) & (k units) Table 125. South America Hydrocortisone Injection Revenue by Country (2021-2026) & (US$ Million) Table 126. South America Hydrocortisone Injection Revenue by Country (2027-2032) & (US$ Million) Table 127. Middle East and Africa Hydrocortisone Injection Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. Middle East and Africa Hydrocortisone Injection Sales by Country (2021-2026) & (k units) Table 129. Middle East and Africa Hydrocortisone Injection Sales by Country (2027-2032) & (k units) Table 130. Middle East and Africa Hydrocortisone Injection Revenue by Country (2021-2026) & (US$ Million) Table 131. Middle East and Africa Hydrocortisone Injection Revenue by Country (2027-2032) & (US$ Million) Table 132. Global Hydrocortisone Injection Sales by Type (2021-2026) & (k units) Table 133. Global Hydrocortisone Injection Sales by Type (2027-2032) & (k units) Table 134. Global Hydrocortisone Injection Sales Market Share by Type (2021-2026) Table 135. Global Hydrocortisone Injection Sales Market Share by Type (2027-2032) Table 136. Global Hydrocortisone Injection Revenue by Type (2021-2026) & (US$ Million) Table 137. Global Hydrocortisone Injection Revenue by Type (2027-2032) & (US$ Million) Table 138. Global Hydrocortisone Injection Revenue Market Share by Type (2021-2026) Table 139. Global Hydrocortisone Injection Revenue Market Share by Type (2027-2032) Table 140. Global Hydrocortisone Injection Price by Type (2021-2026) & (US$/unit) Table 141. Global Hydrocortisone Injection Price by Type (2027-2032) & (US$/unit) Table 142. Global Hydrocortisone Injection Sales by Application (2021-2026) & (k units) Table 143. Global Hydrocortisone Injection Sales by Application (2027-2032) & (k units) Table 144. Global Hydrocortisone Injection Sales Market Share by Application (2021-2026) Table 145. Global Hydrocortisone Injection Sales Market Share by Application (2027-2032) Table 146. Global Hydrocortisone Injection Revenue by Application (2021-2026) & (US$ Million) Table 147. Global Hydrocortisone Injection Revenue by Application (2027-2032) & (US$ Million) Table 148. Global Hydrocortisone Injection Revenue Market Share by Application (2021-2026) Table 149. Global Hydrocortisone Injection Revenue Market Share by Application (2027-2032) Table 150. Global Hydrocortisone Injection Price by Application (2021-2026) & (US$/unit) Table 151. Global Hydrocortisone Injection Price by Application (2027-2032) & (US$/unit) Table 152. Key Raw Materials Table 153. Raw Materials Key Suppliers Table 154. Hydrocortisone Injection Distributors List Table 155. Hydrocortisone Injection Customers List Table 156. Hydrocortisone Injection Industry Trends Table 157. Hydrocortisone Injection Industry Drivers Table 158. Hydrocortisone Injection Industry Restraints Table 159. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Hydrocortisone Injection Product Image Figure 5. Global Hydrocortisone Injection Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Hydrocortisone Injection Market Size (2021-2032) & (US$ Million) Figure 7. Global Hydrocortisone Injection Sales (2021-2032) & (k units) Figure 8. Global Hydrocortisone Injection Average Price (US$/unit) & (2021-2032) Figure 9. Intramuscular Injection Product Image Figure 10. Intravenous Drip Product Image Figure 11. Hospital Product Image Figure 12. Clinics Product Image Figure 13. Other Product Image Figure 14. Global Hydrocortisone Injection Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Hydrocortisone Injection, Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Hydrocortisone Injection Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Hydrocortisone Injection Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Hydrocortisone Injection Sales by Region in 2025 Figure 20. Global Hydrocortisone Injection Revenue by Region in 2025 Figure 21. North America Hydrocortisone Injection Market Size by Country in 2025 Figure 22. North America Hydrocortisone Injection Sales Market Share by Country (2021-2032) Figure 23. North America Hydrocortisone Injection Revenue Market Share by Country (2021-2032) Figure 24. United States Hydrocortisone Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Hydrocortisone Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Mexico Hydrocortisone Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Hydrocortisone Injection Market Size by Country in 2025 Figure 28. Europe Hydrocortisone Injection Sales Market Share by Country (2021-2032) Figure 29. Europe Hydrocortisone Injection Revenue Market Share by Country (2021-2032) Figure 30. Germany Hydrocortisone Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Hydrocortisone Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Hydrocortisone Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Hydrocortisone Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Russia Hydrocortisone Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Spain Hydrocortisone Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands Hydrocortisone Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Switzerland Hydrocortisone Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Sweden Hydrocortisone Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Poland Hydrocortisone Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific Hydrocortisone Injection Market Size by Country in 2025 Figure 41. Asia Pacific Hydrocortisone Injection Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific Hydrocortisone Injection Revenue Market Share by Country (2021-2032) Figure 43. China Hydrocortisone Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan Hydrocortisone Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea Hydrocortisone Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India Hydrocortisone Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia Hydrocortisone Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Taiwan Hydrocortisone Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Hydrocortisone Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Hydrocortisone Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America Hydrocortisone Injection Market Size by Country in 2025 Figure 52. South America Hydrocortisone Injection Sales Market Share by Country (2021-2032) Figure 53. South America Hydrocortisone Injection Revenue Market Share by Country (2021-2032) Figure 54. Brazil Hydrocortisone Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Hydrocortisone Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Chile Hydrocortisone Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Middle East and Africa Hydrocortisone Injection Market Size by Country in 2025 Figure 58. Middle East and Africa Hydrocortisone Injection Sales Market Share by Country (2021-2032) Figure 59. Middle East and Africa Hydrocortisone Injection Revenue Market Share by Country (2021-2032) Figure 60. Egypt Hydrocortisone Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. South Africa Hydrocortisone Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Israel Hydrocortisone Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Türkiye Hydrocortisone Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. GCC Countries Hydrocortisone Injection Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Global Hydrocortisone Injection Sales Market Share by Type (2021-2032) Figure 66. Global Hydrocortisone Injection Revenue Market Share by Type (2021-2032) Figure 67. Global Hydrocortisone Injection Price (US$/unit) by Type (2021-2032) Figure 68. Global Hydrocortisone Injection Sales Market Share by Application (2021-2032) Figure 69. Global Hydrocortisone Injection Revenue Market Share by Application (2021-2032) Figure 70. Global Hydrocortisone Injection Price (US$/unit) by Application (2021-2032) Figure 71. Hydrocortisone Injection Value Chain Figure 72. Hydrocortisone Injection Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Hydrocortisone Injection Industry Opportunities and Challenges

Scope & coverage.

Types
  • Intramuscular Injection
  • Intravenous Drip
Applications
  • Hospital
  • Clinics
  • Other
Companies covered
  • Southwest Pharmaceutical
  • KINGYOR
  • Shiyao YINHU Pharmaceutical
  • CSPC Ouyi Pharmaceutical
  • Maanshan Fengyuan Pharmaceutical
  • Jiangsu Lianhuan Pharmaceutical
  • Jiangsu Kangbao Pharmaceutical
  • Pfizer
  • HUAZHONG Pharmaceutical
  • Hubei Zhongjiachem Pharmaceutical
  • Hebei Tiancheng Pharmaceutical
  • Dalian Holley Kingkong Pharmaceutical
  • Chengdu No.1 Pharmaceutical
  • BIOZEN Pharmaceutical
  • Anhui Changjiang Pharmaceutical
  • Anhui Chengshi Pharmaceutical

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Hydrocortisone Injection Market Size (2021-2032)
  4. 2.2.2 Global Hydrocortisone Injection Sales (2021-2032)
  5. 2.2.3 Global Hydrocortisone Injection Market Average Price (2021-2032)
  6. 2.3 Hydrocortisone Injection by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Intramuscular Injection
  9. 2.3.3 Intravenous Drip
  10. 2.4 Hydrocortisone Injection by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Hospital
  13. 2.4.3 Clinics
  14. 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Hydrocortisone Injection Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Hydrocortisone Injection Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Hydrocortisone Injection Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Hydrocortisone Injection Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Hydrocortisone Injection Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Hydrocortisone Injection, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Hydrocortisone Injection, Product Type & Application
  8. 3.8 Global Manufacturers of Hydrocortisone Injection, Established Date
  9. 3.9 Global Hydrocortisone Injection Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Southwest Pharmaceutical
  2. 4.1.1 Southwest Pharmaceutical Company Information
  3. 4.1.2 Southwest Pharmaceutical Business Overview
  4. 4.1.3 Southwest Pharmaceutical Hydrocortisone Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Southwest Pharmaceutical Hydrocortisone Injection Product Portfolio
  6. 4.1.5 Southwest Pharmaceutical Recent Developments
  7. 4.2 KINGYOR
  8. 4.2.1 KINGYOR Company Information
  9. 4.2.2 KINGYOR Business Overview
  10. 4.2.3 KINGYOR Hydrocortisone Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 KINGYOR Hydrocortisone Injection Product Portfolio
  12. 4.2.5 KINGYOR Recent Developments
  13. 4.3 Shiyao YINHU Pharmaceutical
  14. 4.3.1 Shiyao YINHU Pharmaceutical Company Information
  15. 4.3.2 Shiyao YINHU Pharmaceutical Business Overview
  16. 4.3.3 Shiyao YINHU Pharmaceutical Hydrocortisone Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Shiyao YINHU Pharmaceutical Hydrocortisone Injection Product Portfolio
  18. 4.3.5 Shiyao YINHU Pharmaceutical Recent Developments
  19. 4.4 CSPC Ouyi Pharmaceutical
  20. 4.4.1 CSPC Ouyi Pharmaceutical Company Information
  21. 4.4.2 CSPC Ouyi Pharmaceutical Business Overview
  22. 4.4.3 CSPC Ouyi Pharmaceutical Hydrocortisone Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 CSPC Ouyi Pharmaceutical Hydrocortisone Injection Product Portfolio
  24. 4.4.5 CSPC Ouyi Pharmaceutical Recent Developments
  25. 4.5 Maanshan Fengyuan Pharmaceutical
  26. 4.5.1 Maanshan Fengyuan Pharmaceutical Company Information
  27. 4.5.2 Maanshan Fengyuan Pharmaceutical Business Overview
  28. 4.5.3 Maanshan Fengyuan Pharmaceutical Hydrocortisone Injection Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Maanshan Fengyuan Pharmaceutical Hydrocortisone Injection Product Portfolio
  30. 4.5.5 Maanshan Fengyuan Pharmaceutical Recent Developments
  31. 4.6 Jiangsu Lianhuan Pharmaceutical
  32. 4.6.1 Jiangsu Lianhuan Pharmaceutical Company Information
  33. 4.6.2 Jiangsu Lianhuan Pharmaceutical Business Overview
  34. 4.6.3 Jiangsu Lianhuan Pharmaceutical Hydrocortisone Injection Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Jiangsu Lianhuan Pharmaceutical Hydrocortisone Injection Product Portfolio
  36. 4.6.5 Jiangsu Lianhuan Pharmaceutical Recent Developments
  37. 4.7 Jiangsu Kangbao Pharmaceutical
  38. 4.7.1 Jiangsu Kangbao Pharmaceutical Company Information
  39. 4.7.2 Jiangsu Kangbao Pharmaceutical Business Overview
  40. 4.7.3 Jiangsu Kangbao Pharmaceutical Hydrocortisone Injection Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Jiangsu Kangbao Pharmaceutical Hydrocortisone Injection Product Portfolio
  42. 4.7.5 Jiangsu Kangbao Pharmaceutical Recent Developments
  43. 4.8 Pfizer
  44. 4.8.1 Pfizer Company Information
  45. 4.8.2 Pfizer Business Overview
  46. 4.8.3 Pfizer Hydrocortisone Injection Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Pfizer Hydrocortisone Injection Product Portfolio
  48. 4.8.5 Pfizer Recent Developments
  49. 4.9 HUAZHONG Pharmaceutical
  50. 4.9.1 HUAZHONG Pharmaceutical Company Information
  51. 4.9.2 HUAZHONG Pharmaceutical Business Overview
  52. 4.9.3 HUAZHONG Pharmaceutical Hydrocortisone Injection Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 HUAZHONG Pharmaceutical Hydrocortisone Injection Product Portfolio
  54. 4.9.5 HUAZHONG Pharmaceutical Recent Developments
  55. 4.10 Hubei Zhongjiachem Pharmaceutical
  56. 4.10.1 Hubei Zhongjiachem Pharmaceutical Company Information
  57. 4.10.2 Hubei Zhongjiachem Pharmaceutical Business Overview
  58. 4.10.3 Hubei Zhongjiachem Pharmaceutical Hydrocortisone Injection Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Hubei Zhongjiachem Pharmaceutical Hydrocortisone Injection Product Portfolio
  60. 4.10.5 Hubei Zhongjiachem Pharmaceutical Recent Developments
  61. 4.11 Hebei Tiancheng Pharmaceutical
  62. 4.11.1 Hebei Tiancheng Pharmaceutical Company Information
  63. 4.11.2 Hebei Tiancheng Pharmaceutical Business Overview
  64. 4.11.3 Hebei Tiancheng Pharmaceutical Hydrocortisone Injection Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Hebei Tiancheng Pharmaceutical Hydrocortisone Injection Product Portfolio
  66. 4.11.5 Hebei Tiancheng Pharmaceutical Recent Developments
  67. 4.12 Dalian Holley Kingkong Pharmaceutical
  68. 4.12.1 Dalian Holley Kingkong Pharmaceutical Company Information
  69. 4.12.2 Dalian Holley Kingkong Pharmaceutical Business Overview
  70. 4.12.3 Dalian Holley Kingkong Pharmaceutical Hydrocortisone Injection Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Dalian Holley Kingkong Pharmaceutical Hydrocortisone Injection Product Portfolio
  72. 4.12.5 Dalian Holley Kingkong Pharmaceutical Recent Developments
  73. 4.13 Chengdu No.1 Pharmaceutical
  74. 4.13.1 Chengdu No.1 Pharmaceutical Company Information
  75. 4.13.2 Chengdu No.1 Pharmaceutical Business Overview
  76. 4.13.3 Chengdu No.1 Pharmaceutical Hydrocortisone Injection Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Chengdu No.1 Pharmaceutical Hydrocortisone Injection Product Portfolio
  78. 4.13.5 Chengdu No.1 Pharmaceutical Recent Developments
  79. 4.14 BIOZEN Pharmaceutical
  80. 4.14.1 BIOZEN Pharmaceutical Company Information
  81. 4.14.2 BIOZEN Pharmaceutical Business Overview
  82. 4.14.3 BIOZEN Pharmaceutical Hydrocortisone Injection Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 BIOZEN Pharmaceutical Hydrocortisone Injection Product Portfolio
  84. 4.14.5 BIOZEN Pharmaceutical Recent Developments
  85. 4.15 Anhui Changjiang Pharmaceutical
  86. 4.15.1 Anhui Changjiang Pharmaceutical Company Information
  87. 4.15.2 Anhui Changjiang Pharmaceutical Business Overview
  88. 4.15.3 Anhui Changjiang Pharmaceutical Hydrocortisone Injection Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Anhui Changjiang Pharmaceutical Hydrocortisone Injection Product Portfolio
  90. 4.15.5 Anhui Changjiang Pharmaceutical Recent Developments
  91. 4.16 Anhui Chengshi Pharmaceutical
  92. 4.16.1 Anhui Chengshi Pharmaceutical Company Information
  93. 4.16.2 Anhui Chengshi Pharmaceutical Business Overview
  94. 4.16.3 Anhui Chengshi Pharmaceutical Hydrocortisone Injection Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Anhui Chengshi Pharmaceutical Hydrocortisone Injection Product Portfolio
  96. 4.16.5 Anhui Chengshi Pharmaceutical Recent Developments
5 Global Hydrocortisone Injection Market Scenario by Region
  1. 5.1 Global Hydrocortisone Injection Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Hydrocortisone Injection Sales by Region: 2021-2032
  3. 5.2.1 Global Hydrocortisone Injection Sales by Region: 2021-2026
  4. 5.2.2 Global Hydrocortisone Injection Sales by Region: 2027-2032
  5. 5.3 Global Hydrocortisone Injection Revenue by Region: 2021-2032
  6. 5.3.1 Global Hydrocortisone Injection Revenue by Region: 2021-2026
  7. 5.3.2 Global Hydrocortisone Injection Revenue by Region: 2027-2032
  8. 5.4 North America Hydrocortisone Injection Market Facts & Figures by Country
  9. 5.4.1 North America Hydrocortisone Injection Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Hydrocortisone Injection Sales by Country (2021-2032)
  11. 5.4.3 North America Hydrocortisone Injection Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Hydrocortisone Injection Market Facts & Figures by Country
  16. 5.5.1 Europe Hydrocortisone Injection Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Hydrocortisone Injection Sales by Country (2021-2032)
  18. 5.5.3 Europe Hydrocortisone Injection Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Hydrocortisone Injection Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Hydrocortisone Injection Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Hydrocortisone Injection Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Hydrocortisone Injection Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Hydrocortisone Injection Market Facts & Figures by Country
  41. 5.7.1 South America Hydrocortisone Injection Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Hydrocortisone Injection Sales by Country (2021-2032)
  43. 5.7.3 South America Hydrocortisone Injection Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Hydrocortisone Injection Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Hydrocortisone Injection Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Hydrocortisone Injection Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Hydrocortisone Injection Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Hydrocortisone Injection Sales by Type (2021-2032)
  2. 6.1.1 Global Hydrocortisone Injection Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Hydrocortisone Injection Sales Market Share by Type (2021-2032)
  4. 6.2 Global Hydrocortisone Injection Revenue by Type (2021-2032)
  5. 6.2.1 Global Hydrocortisone Injection Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Hydrocortisone Injection Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Hydrocortisone Injection Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Hydrocortisone Injection Sales by Application (2021-2032)
  2. 7.1.1 Global Hydrocortisone Injection Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Hydrocortisone Injection Sales Market Share by Application (2021-2032)
  4. 7.2 Global Hydrocortisone Injection Revenue by Application (2021-2032)
  5. 7.2.1 Global Hydrocortisone Injection Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Hydrocortisone Injection Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Hydrocortisone Injection Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Hydrocortisone Injection Value Chain Analysis
  2. 8.1.1 Hydrocortisone Injection Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Hydrocortisone Injection Production Mode & Process
  5. 8.2 Hydrocortisone Injection Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Hydrocortisone Injection Distributors
  8. 8.2.3 Hydrocortisone Injection Customers
9 Global Hydrocortisone Injection Analyzing Market Dynamics
  1. 9.1 Hydrocortisone Injection Industry Trends
  2. 9.2 Hydrocortisone Injection Industry Drivers
  3. 9.3 Hydrocortisone Injection Industry Opportunities and Challenges
  4. 9.4 Hydrocortisone Injection Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst